These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8204007)

  • 1. BCL-2 proto-oncogene expression in prostate cancer and its relationship to the prostatic neuroendocrine cell.
    Segal NH; Cohen RJ; Haffejee Z; Savage N
    Arch Pathol Lab Med; 1994 Jun; 118(6):616-8. PubMed ID: 8204007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer.
    McDonnell TJ; Troncoso P; Brisbay SM; Logothetis C; Chung LW; Hsieh JT; Tu SM; Campbell ML
    Cancer Res; 1992 Dec; 52(24):6940-4. PubMed ID: 1458483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumors.
    Cussenot O; Villette JM; Cochand-Priollet B; Berthon P
    Prostate Suppl; 1998; 8():43-51. PubMed ID: 9690663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate-specific expression of Bax delivered by an adenoviral vector induces apoptosis in LNCaP prostate cancer cells.
    Lowe SL; Rubinchik S; Honda T; McDonnell TJ; Dong JY; Norris JS
    Gene Ther; 2001 Sep; 8(18):1363-71. PubMed ID: 11571575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended survivability of prostate cancer cells in the absence of trophic factors: increased proliferation, evasion of apoptosis, and the role of apoptosis proteins.
    Tang DG; Li L; Chopra DP; Porter AT
    Cancer Res; 1998 Aug; 58(15):3466-79. PubMed ID: 9699682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostatic neuroendocrine cells have a unique keratin expression pattern and do not express Bcl-2: cell kinetic features of neuroendocrine cells in the human prostate.
    Xue Y; Verhofstad A; Lange W; Smedts F; Debruyne F; de la Rosette J; Schalken J
    Am J Pathol; 1997 Dec; 151(6):1759-65. PubMed ID: 9403726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of bcl-2 and the progression of human and rodent prostatic cancers.
    Furuya Y; Krajewski S; Epstein JI; Reed JC; Isaacs JT
    Clin Cancer Res; 1996 Feb; 2(2):389-98. PubMed ID: 9816182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroendocrine differentiation in stage D2 prostate cancers.
    Kamiya N; Suzuki H; Kawamura K; Imamoto T; Naya Y; Tochigi N; Kakuta Y; Yamaguchi K; Ishikura H; Ichikawa T
    Int J Urol; 2008 May; 15(5):423-8. PubMed ID: 18452460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bcl-2 protein expression in lung cancer and close correlation with neuroendocrine differentiation.
    Jiang SX; Kameya T; Sato Y; Yanase N; Yoshimura H; Kodama T
    Am J Pathol; 1996 Mar; 148(3):837-46. PubMed ID: 8774138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression.
    Cox ME; Deeble PD; Lakhani S; Parsons SJ
    Cancer Res; 1999 Aug; 59(15):3821-30. PubMed ID: 10447001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of DNA ploidy, bcl-2 and p53 in localized prostate adenocarcinoma incidentally discovered at transurethral prostatectomy.
    Abaza R; Diaz LK; Laskin WB; Pins MR
    J Urol; 2006 Dec; 176(6 Pt 1):2701-5. PubMed ID: 17085199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproic acid induces neuroendocrine differentiation and UGT2B7 up-regulation in human prostate carcinoma cell line.
    Valentini A; Biancolella M; Amati F; Gravina P; Miano R; Chillemi G; Farcomeni A; Bueno S; Vespasiani G; Desideri A; Federici G; Novelli G; Bernardini S
    Drug Metab Dispos; 2007 Jun; 35(6):968-72. PubMed ID: 17371798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of Bcl-2 is required for the progression of prostate cancer cells from an androgen-dependent to an androgen-independent growth stage.
    Lin Y; Fukuchi J; Hiipakka RA; Kokontis JM; Xiang J
    Cell Res; 2007 Jun; 17(6):531-6. PubMed ID: 17404601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroendocrine cells in human prostate over-express the anti-apoptosis protein survivin.
    Xing N; Qian J; Bostwick D; Bergstralh E; Young CY
    Prostate; 2001 Jun; 48(1):7-15. PubMed ID: 11391682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TabBO: a model reflecting common molecular features of androgen-independent prostate cancer.
    Navone NM; Rodriquez-Vargas MC; Benedict WF; Troncoso P; McDonnell TJ; Zhou JH; Luthra R; Logothetis CJ
    Clin Cancer Res; 2000 Mar; 6(3):1190-7. PubMed ID: 10741751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression.
    Lee SO; Chun JY; Nadiminty N; Lou W; Gao AC
    Prostate; 2007 May; 67(7):764-73. PubMed ID: 17373716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis].
    Irie K; Ishida H; Furukawa T; Koyanagi K; Miyamoto Y
    Rinsho Byori; 1996 Jan; 44(1):32-41. PubMed ID: 8691638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of Bcl-2 expression by dihydrotestosterone in hormone sensitive LNCaP-FGC prostate cancer cells.
    Bruckheimer EM; Spurgers K; Weigel NL; Logothetis C; McDonnell TJ
    J Urol; 2003 Apr; 169(4):1553-7. PubMed ID: 12629413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of Bcl-2 during androgen-unresponsive progression of prostate cancer.
    Rothermund CA; Kondrikov D; Lin MF; Vishwanatha JK
    Prostate Cancer Prostatic Dis; 2002; 5(3):236-45. PubMed ID: 12496988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical study of cyclooxygenases in prostatic adenocarcinoma; relationship to apoptosis and Bcl-2 protein expression.
    Tanji N; Kikugawa T; Yokoyama M
    Anticancer Res; 2000; 20(4):2313-9. PubMed ID: 10953290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.